New antibiotic could treat drug-resistant gonorrhea: Study

MISTR: DoxyPEP helps reduce STIs among patients by 50 percent

MISTR, the nation’s largest LGBTQ+ sexual health platform, just marked one year of providing free DoxyPEP, and STI positivity rates have dropped by more than 50 percent among MISTR’s more than 500,000 patients, according a MISTR press release issued this week. In just 12 months, the press release notes, more than 74 percent of patients now request DoxyPEP bundled with their PrEP prescriptions, “highlighting massive demand for this underutilized …

'First after the 1960s': New drug to treat sexually transmitted gonorrhoea

If the drug is approved for gonorrhoea, it will not only be the newest drug to treat the bacterial infection but also a drug to be approved since the 1990s. World

A new pill with gepotidacin could revolutionize the treatment of gonorrhea and face the threat of antibiotic resistance

STI Outbreak in Alaska

Alaska is seeing a dangerous gonorrhea outbreak, while the CDC's STD lab and field staff have been cut. What happens to sexual health when states lose their first line of defense?

Gonorrhea is on the verge of being impossible to treat, but a new antibiotic may alter that course

Rates of antibiotic-resistant gonorrhea have been on the rise across the globe. Reliable treatment for the sexually transmitted infection is down to one medication. This makes a new study showing a new antibiotic to be effective against gonorrhea particularly significant.

Gepotidacin eliminates sexually transmitted bacteria in 93 per cent of cases, in the midst of a global emergency due to the lack of new antimicrobials